Login
$XERS
$16.49 -$0.21 (1.26%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Anh T. Nguyen
Chief Medical Officer
51 Since 2025
1 year
Not stated Not reported
John Shannon Also a director
See Remarks
Title from the Form 4 dated Aug 1, 2026
64 Not stated 2017 $5,042,584
Steven M. Pieper
See Remarks
Title from the Form 4 dated Nov 2, 2026
49 Not stated 2017 $1,874,090
Kevin McCulloch
See Remarks
Title from the Form 4 dated Nov 5, 2026
63 Not stated 2018 $2,270,973
Beth P. Hecht
See Remarks
Title from the Form 4 dated Nov 2, 2026
62 Not stated 2018 $1,895,274

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 23, 2026 · updated by the 8-Ks of Jun 30, 2026 and Nov 2, 2026

Directors
10
serving now
Independent
9 of 10
stated in the proxy
Average tenure
4.0 years
from year joined
CEO also chairs the board
No
Marla Persky
Director Age On board Independent Committees Other public boards 2025 pay Source
Marla Persky
70 2021
5 years
Independent
Audit Committee Nominating and Corporate Governance Committee
Revolo Biotherapeutics Limited $326,500
John Shannon
64 2024
2 years
Not independent None stated None stated Paid as CEO
Dawn Halkuff
55 2021
5 years
Independent
Compensation Committee
None stated $290,500
John Johnson
68 2021
5 years
Independent
Nominating and Corporate Governance Committee
Verastem, Inc., AxoGen, Inc. $276,500
BJ Bormann
67 2021
5 years
Independent
Nominating and Corporate Governance Committee
BioLine Rx Ltd., NanoMedical Systems Inc. $294,500
James Brady
63 2025
1 year
Independent None stated None stated $606,984
Garheng Kong
50 2021
5 years
Independent
Audit Committee
Laboratory Corporation of America Holdings, Lunit, Inc., Smith+Nephew $281,500
Nerissa Kreher Joined Jul 1, 2026
- - Independent - - -
Menassie Taddese Joined Nov 2, 2026
- - Independent
Audit Committee
- -
Jeffrey Sherman Leaving at the meeting
Not stated Not stated Independent
Compensation Committee Nominating and Corporate Governance Committee
None stated $285,500

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support